chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swollen lymph nodes in jaw and neck on the left side of head; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 07May2021 at 09:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included heart disease, bi-polar, post-traumatic stress disorder (PTSD), gastroesophageal reflux disease (GERD), COVID-19 and allergies to pineapples. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN), isosorbide (MANUFACTURER UNKNOWN) and clopidogrel (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. The patient previously took fluoxetine hydrochloride (PROZAC) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 16Apr2021 at 09:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. On 11May2021 at 01:45, the patient experienced swollen lymph nodes in his jaw and neck on the left side of his head. The doctor took a look, and told there were no signs of infection and told it was likely a reaction to the vaccine. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph nodes in jaw and neck on the left side of head was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
1/2 hr to 1 hr later pt was tender @ joint then turned purple for 4 days-(whole finger); about 4-5 hrs later back (spineal column( & all around sides of back were extremely tender esp to touch;
09/29/2021 started not to feel well, like a cold was coming. I had a headache, sore and fatigue.  10/01/2021 Did a rapid home test.  10/02/2021 I went to Urgent Care, because I started to have swollen lymph nodes on back of neck and lower back. The Urgent Care doctor prescribed me Prednisone. I only took for a few days till I went to my primary care on 10/04/2021. 10/03/2021 I began to have a rash on my forehead, he looked at me and said I have shingles.  10/05/2021 I went to my eye doctor since the rash was around my left eye and it was swollen. My primary can me an antiviral for the shingles, and pain med as needed, also a steroid eye drop.
Redness and swelling at inj site 5"x2" long started within 24 hrs. Resolved within 48hrs low grade temp.
Body aches, diarrhea, nausea & headache.  No reactions noted w/in 72 hrs of doses given 7/21, 7/24, 7/28, 8/4, 8/18.  Sxs dev. on 8/26/90.  According to PHN this is similar to syndrome going around in community.
Few hours later my right arm is extremely painful with any movement. Woke up the next morning feeling very achy in my bones. Chills. Peeing very frequently (every 30-60 minutes). Feels like i have the flu (I don't, I've been vaccinated for that already this season)
I started my period a week earlier than usual on 4/6/21. I received my second dose 2.5 weeks before then on 3/19. I typically do not get my period early, especially while on birth control. My stress and health are normal.   I also had a fever of 102* and body aches starting 12 hours after the second dose and that lasted for 24 hours.
Immediately after receiving the MMR in her leg, pt became pale, weak and complained of her eyes being blurry. She said she was having trouble breathing. I gave her some water and sat with her in the waiting room until she felt better. MD's office was very busy.
Approx 3"x4" inflamed, swollen, tender area at injection site.....enlarged and worsened over next 5 days....Treated with Tylenol 2 tabs every 8 hrs and ice to site.
he experienced bad taste for minute or two; swelling around tongue; swelling around cheek; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (he experienced bad taste for minute or two), SWOLLEN TONGUE (swelling around tongue) and SWELLING FACE (swelling around cheek) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced TASTE DISORDER (he experienced bad taste for minute or two), SWOLLEN TONGUE (swelling around tongue) and SWELLING FACE (swelling around cheek). On 14-Mar-2021, TASTE DISORDER (he experienced bad taste for minute or two), SWOLLEN TONGUE (swelling around tongue) and SWELLING FACE (swelling around cheek) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  The caller was calling on behalf of her brother and wanted to knowif the symptoms reported were normal,  if any medications could be recommended , or if Benadryl (diphenhydramine) could be taken half an hour before receiving the second dose of vaccine, scheduled on11-Apr-2021.  No treatment information was reported.
Redness, swelling, warmth, firmness 10 cm diameter left deltoid area. Appeared day following vaccines and persisted.
6 mth old male with Trisomy 21 received Rotavirus vaccine 11-27-12, developed blood in stool 12-03-12. Abdominal US showed intussusception. Attempted laparoscopic repair converted to open reduction. Discharge home after 2 days.
pt recvd vax & exp urticaria & wheezing; pt treated in ER: referred to allergist; skin tested pos to thimerosal ingredient of vax;
pneumonia; first dose of the Shingrix vaccine on 01/15/2020; This case was reported by a consumer via call center representative and described the occurrence of pneumonia in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 15th January 2020, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. In May 2020, between 3 and 5 months after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced pneumonia (serious criteria hospitalization and GSK medically significant). On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the pneumonia and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the pneumonia to be related to Shingrix.  Additional details were reported as follows: The patient received the first dose of the Shingrix vaccine and in May 2020, she was admitted to the hospital with pneumonia. The day of reporting was her 6th month mark and she did not receive her second dose yet and also did not know when she would receive it which, led to incomplete course of vaccination. The reporter did not consent to follow up.
Fever after second dose; thought about taking his life; went through an intense depression and started to cry; headaches were intense and extreme; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SUICIDAL IDEATION (thought about taking his life) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced HEADACHE (headaches were intense and extreme). On 10-Apr-2021, the patient experienced SUICIDAL IDEATION (thought about taking his life) (seriousness criterion life threatening) and DEPRESSION (went through an intense depression and started to cry). On an unknown date, the patient experienced PYREXIA (Fever after second dose). On 10-Apr-2021, SUICIDAL IDEATION (thought about taking his life) and DEPRESSION (went through an intense depression and started to cry) had resolved. At the time of the report, HEADACHE (headaches were intense and extreme) had resolved and PYREXIA (Fever after second dose) outcome was unknown.            No adverse event as Medical History was reported. Treatment included acetaminophen.  Concomitant medication was not reported.  The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in response to the event is not applicable. On 02-Apr-2021, the patient experienced HEADACHE (headaches were intense and extreme). He also described the headaches as a dull, not throbbing pain.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-104303 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient had high fever, 103-104, 6-8 hours after vaccine was given also red area on leg where vaccine was given.
Patient reported headache, fatigue and severe muscle pain that he noticed upon waking up.  He also stated he had confusion, lightheadedness and a loss of vision that happened a few minutes after waking.  He was in the process of making a sandwich to get ready for work and couldn't figure out why he was making a sandwich and that he was going to work.  Patient then experienced the loss of vision and lightheadedness that was accompanied by nausea.  He was unable to go to work.
fever; chills; pain at injection site; This is a spontaneous report received from a contactable consumer (patient) via COVID-19 Adverse Event Self-Reporting Solution (COVAES).   A 28-year-old non-pregnant female patient received first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581), via an unspecified route of administration, administered in the left arm on 09Feb2021,at  11:45 as a single dose for covid-19 immunization.  Medical history included bipolar 2, depression, anxiety and obesity from unknown dates. Concomitant medications included alprazolam (XANAX) taken for an unspecified indication, start and stop date were not reported; venlafaxine hydrochloride (VENLAFAXINE XR) taken for an unspecified indication, start and stop date were not reported; cetirizine hydrochloride (ZYRTEC) taken for an unspecified indication, start and stop date were not reported, zolpidem tartrate (AMBIEN) taken for an unspecified indication, start and stop date were not reported; lamotrigine (LAMICTAL XR) taken for an unspecified indication, start and stop date were not reported. The patient had allergy to codeine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 09Feb2021, at 21:00 the patient experienced fever, chills, pain at injection site with outcome of recovered on 12Feb2021. Details were as follows: noted fever and chills each night for three nights after first dose and pain at injection site for three days. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of fever, chills, pain at injection site; the treatment taken for the adverse events included ibuprofen (MANUFACTURER UNKNOWN). The patient underwent lab tests and procedures which includes Saliva RT PCR: COVID  test result was negative on 05Mar2021. The outcome of fever, chills, pain at injection site was recovered on 12Feb2021.
Myalgia, NauseaVomiting, ACHY, TIRED, UPSET STOMACH, CHILLS Narrative:   Other Relevant History:
This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 61-year-old female patient who received SHINGRIX (batch number YF42409 ?, expiry date 30th June 2019) for prophylaxis. On 23rd October 2018, the patient received SHINGRIX (intramuscular). On an unknown date, less than a month after receiving SHINGRIX, the patient experienced pain in arm, swelling arm and injected limb mobility decreased. On an unknown date, the outcome of the pain in arm, swelling arm and injected limb mobility decreased were not recovered/not resolved. It was unknown if the reporter considered the pain in arm, swelling arm and injected limb mobility decreased to be related to SHINGRIX. Additional details were reported as follow: The patient received SHINGRIX on the right arm. In 2018, after vaccination the patient had difficulty using right arm due to pain and bad swelling. The patient was not available to asked if it was okay for physician follow up. Clarification has been raised for batch number.
Stomach cramps, mild headache, mild earache, slight dizziness, mild hives, general not so good feeling still lingers after 2.5 weeks, although went to work and no fever or doctor visits.
The patient felt lightheaded & briefly blacked out 3-5 minutes after the injection. EMS was notified. Patient's vitals were examine by EMS after which patient elected not to be taken to the hospital. Patient returned home and will continue to monitor for improvement.
Within minutes of giving vaccine the skin at the site of vaccination developed urticarial reaction.  Benedryl was administered and the urticaria resolved.
12/29/20 Moderna vaccine 1/26/21 Moderna vaccine  11/17/21 Pfizer booster 11/25/21 Episodes of chest pressure (not acute pain, non-radiating) and feeling as though my heart rate was irregular. Felt like I needed to take a deep breath. These episodes lasted for an hour or so. I had experienced a similar episode the previous day but it was of a much shorter duration and didn't register s anything abnormal until it happened again and lasted much longer. 11/30/21Same experience, this this time at night after going to bed. Pulse felt irregular @ times and it was difficult to sleep. 12/1/21Senior director informed. Encouraged to follow up with PCP. 12/1/21 PCP appointment not available 12/2/21 Saw PCP. Blood work drawn and 48 hour halter monitor ordered. 12/3/21 Went to employee health No previous cardiac history, no family history of cardiac disease, no cardiac medications, No HTN
Information has been receive from a pharmacist referring to a 50 year old female patient with high cholesterol, diabetes, depression, neuropathy. The patient had allergy with penicillin. On 10-JUL-2015 the patient was vaccinated with ZOSTAVAX (dose was unknown, lot # K020802 and expiry date: 31-JAN-2016, subcutaneous). Concomitant therapies included pravastatin, sertraline, metformin, gabapentin and NAPROXEN. On 12-JUL-2015 the patient developed pain, redness and swelling at the injection site. No lab diagnostics studies were performed. As a result, the patient started ADVIL for treatment. The patient went to see the pharmacist for medical attention. The patient had not recovered at the time of report. Additional information has been requested.
Pt. noticed itching, redness, swelling, soreness within 2 hours of vaccination. Iced area. Next day - induration at site with swelling and redness. By 10/10 -> all clear.
SkinRash & Rash Narrative:  redness at injection site  Other Relevant History:
c/o pain & redness & swelling on  rt upper arm w/size of 15cm x 2mm;
a bit more depressed/more nonproductive; Feel run down/ Sluggish; irritated; Injection site tender; Very fatigued; very slight chills; Feverish; Subpar/under the weather; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP 7534), via an unspecified route of administration in the right arm on 23Mar2021 at 14:45 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included life was ruining, depression, chronic anxiety, OCD, insomnia, chronic adverse effects from accutane poisoning and severe neck discs injuries. The patient was allergic to unspecified medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received unspecified concomitant medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 23March2021 at 16:00, the patient experienced injection site tender, was irritated, felt very fatigued especially the next day and night. The patient felt feverish, had very slight chills, felt run down and sluggish, tired, subpar/under the weather, a bit more depressed and more non-productive. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events injection site tender, irritated, very fatigued, feverish, very slight chills, feel run down/sluggish, subpar//under the weather and a bit more depressed/more nonproductive. The clinical outcomes of the events injection site tender, irritated, very fatigued, feverish, very slight chills, feel run down/sluggish, subpar//under the weather and a bit more depressed/more nonproductive were not recovered at the time of the report.   No follow-up attempts are possible. No further information is expected.
Expired Pneumovax-23 administered to patient. Will get repeat dose at next follow up appointment in October 2023.
dose expired 13Sep2021 at 1 AM; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose expired 13Sep2021 at 1 AM) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose expired 13Sep2021 at 1 AM). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose expired 13Sep2021 at 1 AM) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.  The vaccine was first punctured on 13-Sep-2021 at 1 PM, so it should have expired twelve hours later. The vaccine was administered to the patient on 16-Sep-2021.
Neck started to hurt; pain; Two lumps in her lymph node by the neck on top by the collar bone; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A 69-year-old female patient received bnt162b2 (BNT162B2), administration date 18Mar2021 09:15 (Lot number: EN6208) at the age of 69 years as dose 2, single for COVID-19 immunization. Relevant medical history included: "Blood pressure" (unspecified if ongoing). Concomitant medication(s) included: VITAMIN D [VITAMIN D NOS]; LOSARTAN. Vaccination history included: BNT162B2 (DOSE 1), for COVID-19 immunization. The following information was reported: NECK PAIN (non-serious) with onset 19Mar2021 21:30, outcome "not recovered", described as "Neck started to hurt; pain"; LYMPHADENOPATHY (non-serious) with onset 19Mar2021 21:30, outcome "unknown", described as "Two lumps in her lymph node by the neck on top by the collar bone". Therapeutic measures were taken as a result of neck pain, lymphadenopathy.  Additional Information: The patient takes unspecified blood pressure medication. The patient received her second shot COVID-19 vaccine on Thursday morning at 9:15 AM and had no side effects on Thursday or Friday. Last night (19Mar2021), around 9:30 PM, the patient's neck started to hurt, and it got worse and worse and when she touched her neck, she had two lumps in her lymph node by the neck on top by the collar bone. The patient took some paracetamol (TYLENOL) as treatment. The patient did go and saw that this is part of a side effect from Pfizer and so she just wanted to know if she should put warm compresses or cold compresses on it to help with the pain.  No follow-up attempts are possible. No further information is expected.
Patient had signs and symptoms of anaphylaxis approximately 10 minutes s/p administration of first Pfizer COVID-19 vaccine.  Within the first 10 minutes (max) of receiving vaccine , patient reported to monitoring RN that she was having some new feelings in her throat.  She was brought to the sick bay area and attended to by myself with assistance of 2 other members of the immunization team.  She progressively developed additional sx:  throat tightness, SOB, "tongue feels weird", hoarse voice, and onset of coughing.  Lips appeared to have swelling (later confirmed when lip size lessened after Epi administration), lung sounds & throat exam were normal, pulse weak but normal rate, skin pale, warm & dry.   Epinephrine administered IM to left lateral thigh, followed by 50mg Benadryl IM to R deltoid.  Within 5-8minutes s/p Epi administration, patient reported improvement of symptoms.  EMS was called, per protocol, patient refused their advised transport to ED, medical control at Community Medical Center was contacted by EMS,  with whom patient then spoke directly.  Patient again refused transport,  afterwhich ED physician called in prescriptions for Epi-Pen and oral steroid for her,  with instructions given to patient  on home care.  Vital signs remained stable, and patient was escorted with steady gait & without any signs of distress to car (picked up by a family member) .  At time of departure, patient reported feeling much improved, voice was normal, skin was pink/warm/dry, respirations even & unlabored, pulse strong, and patient had drank water without problems,   Pt was contacted the following day by myself, and she reported that no complications arose overnight and she was doing "good".  See scanned record of event
Pain in upper arm, over a three month time period. The pain is now also in the shoulder and is affecting mobility. I also hear popping when I move my shoulder.
Patient received the vaccines on 10/17/23. Later that day her left arm and shoulder started hurting with extreme pain. Se rated the pain 10/10. On Saturday 10/21/23 she went to the emergency room, and they recommended she take Gabapentin for nerve pain. When she went to the emergency room, she had no strength in her arm and could not lift it up.  The Gabapentin eased her pain but there was still discomfort and no strength in the arm. She had to go out of town and when she came back, she saw her primary doctor. This doctor prescribed her Gabapentin 300mg twice daily, a referral to an Orthopedic doctor and an ultrasound of the arm. She then came into the pharmacy to report the event.